Skip to content
Search

Latest Stories

GPhC appoints Louise Edwards as new Chief Strategy Officer

GPhC appoints Louise Edwards as new Chief Strategy Officer

Louise will succeed Mark Voce who is taking early retirement from the GPhC’s position in July 2024

The General Pharmaceutical Council (GPhC) has promoted Louise Edwards to the position of Chief Strategy Officer and Deputy Registrar.


Louise is currently the Director of Regulation and Digital Transformation at the Electoral Commission, responsible for the organisation’s regulatory work and digital, data, technology and facilities infrastructure.

This includes funding and spending at elections and referendums, registering political parties, enforcement work, and data and information management.

Louise will take over Mark Voce, the GPhC’s current Chief Strategy Officer and Deputy Registrar, who is retiring early in July 2024.

Louise said: "Pharmacy services are at the heart of health care for many people. Having effective regulation and standards in place can transform and give confidence in the quality of care that people receive.

“I am delighted to be appointed as the new Chief Strategy Officer and Deputy Registrar of the General Pharmaceutical Council, and having the opportunity to deliver its vital work to improve the health and well-being of people using pharmacy services.”

The Chief Strategy Officer is one of the four Chief Officers who share delegated authority from the Chief Executive & Registrar to lead the organisation and provide direction to senior management colleagues.

In her role as Chief Strategy Officer and Deputy Registrar, Louise will oversee the GPhC's strategy, pharmacy education and training, regulation reform, equality, diversity and inclusion, as well as its public affairs and external communication work across all teams. She will ensure these collectively follow a single strategic approach.

Duncan Rudkin, GPhC Chief Executive, said: “Our Chief Strategy Officer plays an absolutely critical role in delivering our vision and objectives. I am delighted that Louise will be taking on the role when she joins us in July, and I look forward to working closely with her.”

Duncan also paid tribute to Mark for “the enormous contribution he has made to pharmacy regulation” during his time in this role, and in his previous roles as Director of Education and Standards, and Head of Inspection.

“Mark’s achievements include leading our programme of work to transform the education and training of pharmacists and pharmacy technicians, both before and after registration.

“Mark has worked closely and effectively with stakeholders across Great Britain to introduce once-in-a-generation reforms which will mean that from 2026, all newly qualified pharmacists will be independent prescribers when they join the register,” he added.

According to Duncan, Louise will continue Mark's work to ensure that the regulation of the education and training of pharmacists and pharmacy technicians is strategically designed, implemented and developed to deliver on the vision agreed by the Council.

Louise will also oversee the development and evaluation of GPhC’s next five-year strategic plan, aimed at realising its vision for safe and effective pharmacy care at the heart of healthier communities.

Prior to joining the Electoral Commission, Louise worked for a range of regulators including the Charity Commission for England and Wales, The Independent Parliamentary Standards Authority, Ofgem and the Home Office.

More For You

Professor Sir Stephen Powis at a press briefing

Professor Sir Stephen Powis, was appointed national medical director of NHS England in 2018

NHS

NHS England’s top doctor to step down following Amanda Pritchard’s resignation

Just a week after NHS England chief executive Amanda Pritchard announced her resignation, the organisation’s national medical director, Professor Sir Stephen Powis, has confirmed he will step down this summer after more than seven years in the role.

In a statement released on Thursday, Professor Powis revealed that he had informed Pritchard of his intention to leave in a letter back in January.

Keep ReadingShow less
PDA calls on GP practices to use funding boost to improve job security for pharmacists

Now, it is time to focus on the community pharmacy contract

gettyimages

PDA urges GP practices to ensure funding boost supports employed pharmacists

The Pharmacists' Defence Association (PDA) has called on GP practicesto ensure that all healthcare professionals they employ, including pharmacists, benefit from the 7.2% funding boost they received under a newly agreed contract.

GP employers are encouraged to improve “job security, pay and conditions” for employees with this increased funding.

Keep ReadingShow less
Fourth Shift: Investment in Innovative Medicines Crucial for NHS 10-Year Plan Success

Medicines should be viewed as an investment rather than a cost

gettyimages

ABPI wants to see a ‘fourth shift’ in NHS 10-Year Health Plan


The Association of the British Pharmaceutical Industry (ABPI) has called on the government to increase investment in innovative medicines and vaccines, describing it as a crucial “fourth shift” necessary to ensure the NHS is fit for the future.

Keep ReadingShow less
Asda pharmacy launches UK’s first adult earache service

Asda makes ear health more accessible for everyone

gettyimages

Asda pharmacy launches £25 adult earache service

British supermarket chain Asda has launched the “UK’s first” adult earache service, aiming to reduce the burden on NHS services by eliminating the need for a GP appointment.

Priced at £25, the service allows patients aged 18 and over to book same-day appointments with qualified Asda pharmacists at any of its 226 pharmacies in England.

Keep ReadingShow less
Cat Smith MP Leads Call for Urgent Action

Health minister Wes Streeting

Pic credit: Getty Images

Urgent review into medicine shortages needed, ministers tell Streeting

Health minister Wes Streeting has been urged by 45 MPs to call an urgent review into medicine shortages that is impacting the health and safety of patients.

The news comes on the back of the death David Compton, a 44-year-old man who fell and suffered a heart attack which has been linked to him not being able to get medication for epilepsy.

Keep ReadingShow less